CHRISTOPHER LYNCH: Open Payments
NPI 1568402683 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$547 in 30 payments from 19 companies in 2025. Trend: 2023 $2,260 · 2024 $2,020 · 2025 $547
Food & beverage: $547
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $65 |
| Lilly USA, LLC | 3 | $62 |
| GlaxoSmithKline, LLC. | 4 | $61 |
| PFIZER INC. | 3 | $46 |
| Novartis Pharmaceuticals Corporation | 2 | $45 |
| Verity Pharmaceuticals Inc. | 1 | $33 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $24 |
| Medtronic, Inc. | 1 | $22 |
| Esperion Therapeutics, Inc. | 1 | $19 |
Products named: MOUNJARO, LEQVIO, Tlando, TRELEGY ELLIPTA, SHINGRIX, Bard Urinary Drainage Bag, QULIPTA, VRAYLAR.
Industry payments across MO — which companies pay providers there.
